This issue of Hematology/Oncology Clinics is focused on Hodgkin's Lymphoma and covers such topics as First HRS-cell line L428 and the detection of the CD-30 Antigen , “Normal“ CD30-B-lymphocytes, CD-30-Antigen, Combination-Chemo-Radiotherapy, Early intensification (escBEACOPP), Customized/Targeted Therapy, and more.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 6 6. Preface - p. 7 7. First Hodgkin Cell Line L428 and the CD30 Antigen - p. 8 8. Advancing Antibody Drug Conjugation - p. 13 9. Brentuximab Vedotin for the Treatment of Patients with Hodgkin Lymphoma - p. 18 10. Combination Chemoradiotherapy in Early Hodgkin Lymphoma - p. 21 11. Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma - p. 29 12. Early Intensification Treatment Approach in Advanced-stage Hodgkin Lymphoma - p. 37 13. Induction Therapy for Advanced-stage Hodgkin Lymphoma - p. 43 14. FDG-PET Response–adapted Therapy - p. 49 15. Customized Targeted Therapy in Hodgkin Lymphoma - p. 58 16. Relapsed/Refractory Hodgkin Lymphoma - p. 66 17. Index - p. 79
No hay muestra disponible
No hay ficha técnica disponible
This issue of Hematology/Oncology Clinics is focused on Hodgkin's Lymphoma and covers such topics as First HRS-cell line L428 and the detection of the CD-30 Antigen , “Normal“ CD30-B-lymphocytes, CD-30-Antigen, Combination-Chemo-Radiotherapy, Early intensification (escBEACOPP), Customized/Targeted Therapy, and more.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Contributors - p. 4 5. Forthcoming Issues - p. 6 6. Preface - p. 7 7. First Hodgkin Cell Line L428 and the CD30 Antigen - p. 8 8. Advancing Antibody Drug Conjugation - p. 13 9. Brentuximab Vedotin for the Treatment of Patients with Hodgkin Lymphoma - p. 18 10. Combination Chemoradiotherapy in Early Hodgkin Lymphoma - p. 21 11. Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma - p. 29 12. Early Intensification Treatment Approach in Advanced-stage Hodgkin Lymphoma - p. 37 13. Induction Therapy for Advanced-stage Hodgkin Lymphoma - p. 43 14. FDG-PET Response–adapted Therapy - p. 49 15. Customized Targeted Therapy in Hodgkin Lymphoma - p. 58 16. Relapsed/Refractory Hodgkin Lymphoma - p. 66 17. Index - p. 79
No hay muestra disponible
No hay ficha técnica disponible
